Patrick Hensel
Research Subjects
Patrick Hensel has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Domenico Santoro
Department of Small Animal Clinical Sciences, College of Veterinary Medicine University of Florida Gainesville Florida USA
4 shared publications - Cherie M. Pucheu-Haston
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, 70803, USA
3 shared publications - Chie Tamamoto‐Mochizuki
Department of Clinical Sciences, College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA
3 shared publications - Manolis N. Saridomichelakis
Clinic of Medicine, Faculty of Veterinary Science University of Thessaly Karditsa Greece
3 shared publications - Melissa Eisenschenk
Pet Dermatology Clinic Maple Grove Minnesota USA
3 shared publications for the International Committee on Allergic Diseases of Animals (ICADA)
3 shared publications
Latest Publications
- 2 April 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (2) , 58-64
Update on canine atopic dermatitis
Canine atopic dermatitis is a hereditary, generally pruritic and predominantly T-cell driven inflammatory skin disease involving interplay between skin barrier abnormalities, allergen sensitisation and microbial dysbiosis. Canine atopic dermatitis is a pruritic disease, which most often appears at 1–3 years of age, commonly affecting body areas such as ears, axillae, inguinal area and feet. The chronic nature of canine atopic dermatitis means it also has a significant impact on the dog's quality of life. The diagnosis of canine atopic dermatitis is based on clinical presentation and exclusion of other diseases with a similar clinical presentation, such as ectoparasitic infestations, microbial skin infections and food allergies. Allergy testing, eg by intradermal testing or allergen-specific IgE serology testing, is a useful tool to identify the responsible allergens for inclusion in allergen-specific immunotherapy. However, allergy testing should not be used as a diagnostic tool. Depending on the severity of the disease and expectations of owners, a combination of controlling flare factors (eg, strict flea prevention, diet limitation), symptomatic treatments (eg glucocorticoids, ciclosporin, oclacitinib, ilunocitinib, atinvicitinib, lokivetmab), and allergen-targeted interventions (eg allergen-specific immunotherapy, allergen avoidance) is recommended. Most dogs will require lifelong therapy and the management of atopic dermatitis will require regular adjustments.
- 2 April 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (2) , 58-64
Update on canine atopic dermatitis
Canine atopic dermatitis is a hereditary, generally pruritic and predominantly T-cell driven inflammatory skin disease involving interplay between skin barrier abnormalities, allergen sensitisation and microbial dysbiosis. Canine atopic dermatitis is a pruritic disease, which most often appears at 1–3 years of age, commonly affecting body areas such as ears, axillae, inguinal area and feet. The chronic nature of canine atopic dermatitis means it also has a significant impact on the dog's quality of life. The diagnosis of canine atopic dermatitis is based on clinical presentation and exclusion of other diseases with a similar clinical presentation, such as ectoparasitic infestations, microbial skin infections and food allergies. Allergy testing, eg by intradermal testing or allergen-specific IgE serology testing, is a useful tool to identify the responsible allergens for inclusion in allergen-specific immunotherapy. However, allergy testing should not be used as a diagnostic tool. Depending on the severity of the disease and expectations of owners, a combination of controlling flare factors (eg, strict flea prevention, diet limitation), symptomatic treatments (eg glucocorticoids, ciclosporin, oclacitinib, ilunocitinib, atinvicitinib, lokivetmab), and allergen-targeted interventions (eg allergen-specific immunotherapy, allergen avoidance) is recommended. Most dogs will require lifelong therapy and the management of atopic dermatitis will require regular adjustments.
- Open Access
- 22 November 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (1) , 5-14
Update on the skin barrier, cutaneous microbiome and host defence peptides in canine atopic dermatitis
Background: Canine atopic dermatitis (AD) is a complex inflammatory skin disease associated with cutaneous microbiome, immunological and skin barrier alterations. This review summarises the current evidence on skin barrier defects and on cutaneous microbiome dysfunction in canine AD.Objective: To this aim, online citation databases, abstracts and proceedings from international meetings on skin barrier and cutaneous microbiome published between 2015 and 2023 were reviewed.Results: Since the last update on the pathogenesis of canine AD, published by the International Committee on Allergic Diseases of Animals in 2015, 49 articles have been published on skin barrier function, cutaneous/aural innate immunity and the cutaneous/aural microbiome in atopic dogs. Skin barrier dysfunction and cutaneous microbial dysbiosis are essential players in the pathogenesis of canine AD. It is still unclear if such alterations are primary or secondary to cutaneous inflammation, although some evidence supports their primary involvement in the pathogenesis of canine AD.Conclusion and Clinical Relevance: Although many studies have been published since 2015, the understanding of the cutaneous host–microbe interaction is still unclear, as is the role that cutaneous dysbiosis plays in the development and/or worsening of canine AD. More studies are needed aiming to design new therapeutic approaches to restore the skin barrier, to increase and optimise the cutaneous natural defences, and to rebalance the cutaneous microbiome.
- 22 November 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (1) , 5-14
Open AccessUpdate on the skin barrier, cutaneous microbiome and host defence peptides in canine atopic dermatitis
Background: Canine atopic dermatitis (AD) is a complex inflammatory skin disease associated with cutaneous microbiome, immunological and skin barrier alterations. This review summarises the current evidence on skin barrier defects and on cutaneous microbiome dysfunction in canine AD.Objective: To this aim, online citation databases, abstracts and proceedings from international meetings on skin barrier and cutaneous microbiome published between 2015 and 2023 were reviewed.Results: Since the last update on the pathogenesis of canine AD, published by the International Committee on Allergic Diseases of Animals in 2015, 49 articles have been published on skin barrier function, cutaneous/aural innate immunity and the cutaneous/aural microbiome in atopic dogs. Skin barrier dysfunction and cutaneous microbial dysbiosis are essential players in the pathogenesis of canine AD. It is still unclear if such alterations are primary or secondary to cutaneous inflammation, although some evidence supports their primary involvement in the pathogenesis of canine AD.Conclusion and Clinical Relevance: Although many studies have been published since 2015, the understanding of the cutaneous host–microbe interaction is still unclear, as is the role that cutaneous dysbiosis plays in the development and/or worsening of canine AD. More studies are needed aiming to design new therapeutic approaches to restore the skin barrier, to increase and optimise the cutaneous natural defences, and to rebalance the cutaneous microbiome.
- Open Access
- 15 October 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (1) , 15-24
Update on the role of genetic factors, environmental factors and allergens in canine atopic dermatitis
Background: Canine atopic dermatitis (cAD) is a common, complex and multifactorial disease involving, among others, genetic predisposition, environmental factors and allergic sensitisation.Objective: This review summarises the current evidence on the role of genetic and environmental factors and allergic sensitisation in the pathogenesis of cAD since the last review by ICADA in 2015.Materials and Methods: Online citation databases and proceedings from international meetings on genetic factors, environmental factors and allergens relevant to cAD that had been published between 2015 and 2022 were reviewed.Results: Despite intensive research efforts, the detailed genetic background predisposing to cAD and the effect of a wide range of environmental factors still need more clarification. Genome‐wide association studies and investigations on genetic biomarkers, such as microRNAs, have provided some new information. Environmental factors appear to play a major role. Lifestyle, especially during puppyhood, appears to have an important impact on the developing immune system. Factors such as growing up in a rural environment, large size of family, contact with other animals, and a nonprocessed meat‐based diet may reduce the risk for subsequent development of cAD. It appears that Toxocara canis infection may have a protective effect against Dermatophagoides farinae‐induced cAD. House dust mites (D. farinae and D. pteronyssinus) remain the most common allergen group to which atopic dogs react. Currently, the major allergens related to D. farinae in dogs include Der f 2, Der f 15, Der f 18 and Zen 1.Conclusions and Clinical Relevance: Canine atopic dermatitis remains a complex, genetically heterogeneous disease that is influenced by multiple environmental factors. Further, well‐designed studies are necessary to shed more light on the role of genetics, environmental factors and major allergens in the pathogenesis of cAD.
- 15 October 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (1) , 15-24
Open AccessUpdate on the role of genetic factors, environmental factors and allergens in canine atopic dermatitis
Background: Canine atopic dermatitis (cAD) is a common, complex and multifactorial disease involving, among others, genetic predisposition, environmental factors and allergic sensitisation.Objective: This review summarises the current evidence on the role of genetic and environmental factors and allergic sensitisation in the pathogenesis of cAD since the last review by ICADA in 2015.Materials and Methods: Online citation databases and proceedings from international meetings on genetic factors, environmental factors and allergens relevant to cAD that had been published between 2015 and 2022 were reviewed.Results: Despite intensive research efforts, the detailed genetic background predisposing to cAD and the effect of a wide range of environmental factors still need more clarification. Genome‐wide association studies and investigations on genetic biomarkers, such as microRNAs, have provided some new information. Environmental factors appear to play a major role. Lifestyle, especially during puppyhood, appears to have an important impact on the developing immune system. Factors such as growing up in a rural environment, large size of family, contact with other animals, and a nonprocessed meat‐based diet may reduce the risk for subsequent development of cAD. It appears that Toxocara canis infection may have a protective effect against Dermatophagoides farinae‐induced cAD. House dust mites (D. farinae and D. pteronyssinus) remain the most common allergen group to which atopic dogs react. Currently, the major allergens related to D. farinae in dogs include Der f 2, Der f 15, Der f 18 and Zen 1.Conclusions and Clinical Relevance: Canine atopic dermatitis remains a complex, genetically heterogeneous disease that is influenced by multiple environmental factors. Further, well‐designed studies are necessary to shed more light on the role of genetics, environmental factors and major allergens in the pathogenesis of cAD.
- Open Access
- 23 July 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (1) , 25-39
Update on the role of cytokines and chemokines in canine atopic dermatitis
Background: Cytokines and chemokines play central roles in the pathogenesis of canine atopic dermatitis (cAD). Numerous studies have been published and provide new insights into their roles in cAD.Objectives: To summarise the research updates on the role of cytokines and chemokines in the pathogenesis of cAD since the last review by the International Committee on Allergic Diseases of Animals in 2015.Material and Methods: Online citation databases, abstracts and proceedings from international meetings on cytokines and chemokines relevant to cAD that had been published between 2015 and 2022 were reviewed.Results: Advances in technologies have allowed the simultaneous analysis of a broader range of cytokines and chemokines, which revealed an upregulation of a multipolar immunological axis (Th1, Th2, Th17 and Th22) in cAD. Most studies focused on specific cytokines, which were proposed as potential novel biomarkers and/or therapeutic targets for cAD, such as interleukin‐31. Most other cytokines and chemokines had inconsistent results, perhaps as a consequence of their varied involvement in the pathogenesis of different endotypes of cAD.Conclusions and Clinical Relevance: Inconsistent results for many cytokines and chemokines illustrate the difficulty of studying the complex cytokine and chemokine networks in cAD, and highlight the need for more comprehensive and structured studies in the future.
- 23 July 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (1) , 25-39
Open AccessUpdate on the role of cytokines and chemokines in canine atopic dermatitis
Background: Cytokines and chemokines play central roles in the pathogenesis of canine atopic dermatitis (cAD). Numerous studies have been published and provide new insights into their roles in cAD.Objectives: To summarise the research updates on the role of cytokines and chemokines in the pathogenesis of cAD since the last review by the International Committee on Allergic Diseases of Animals in 2015.Material and Methods: Online citation databases, abstracts and proceedings from international meetings on cytokines and chemokines relevant to cAD that had been published between 2015 and 2022 were reviewed.Results: Advances in technologies have allowed the simultaneous analysis of a broader range of cytokines and chemokines, which revealed an upregulation of a multipolar immunological axis (Th1, Th2, Th17 and Th22) in cAD. Most studies focused on specific cytokines, which were proposed as potential novel biomarkers and/or therapeutic targets for cAD, such as interleukin‐31. Most other cytokines and chemokines had inconsistent results, perhaps as a consequence of their varied involvement in the pathogenesis of different endotypes of cAD.Conclusions and Clinical Relevance: Inconsistent results for many cytokines and chemokines illustrate the difficulty of studying the complex cytokine and chemokine networks in cAD, and highlight the need for more comprehensive and structured studies in the future.
- Top Cited PapersOpen Access
- 11 August 2015
- Published by Springer Nature in BMC Veterinary Research
- Vol. 11 (1) , 1-13
Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification
Canine atopic dermatitis (AD) is a common, genetically predisposed, inflammatory and pruritic skin disease. The variation in clinical presentations, due to genetic factors, extent of the lesions, stage of the disease, secondary infections, as well as resemblance to other non-atopic related skin diseases, can complicate a diagnosis of canine AD. A sub-group of the International Committee for Allergic Diseases in Animals (ICADA) was tasked with the development of a set of practical guidelines that can be used to assist practitioners and researchers in the diagnosis of canine AD. Online citation databases and abstracts from international meetings were searched for publications related to the topic, and combined with expert opinion where necessary. The final set of guidelines was approved by the entire ICADA committee. A total of 81 publications relevant for this review were identified. The guidelines generated focus on three aspects of the diagnostic approach: The diagnosis of canine AD is based on meeting clinical criteria and ruling out other possible causes with similar clinical signs. Flea combing, skin scraping and cytology should be performed, where necessary, as part of a thorough work-up. Elimination diet trials are required for patients with perennial pruritus and/or concurrent gastrointestinal signs. Once a clinical diagnosis of canine AD is made, allergy testing can be performed to identify potential causative allergens for allergen-specific immunotherapy.
- 11 August 2015
- Published by Springer Nature in BMC Veterinary Research
- Vol. 11 (1) , 1-13
Top Cited PapersOpen AccessCanine atopic dermatitis: detailed guidelines for diagnosis and allergen identification
Canine atopic dermatitis (AD) is a common, genetically predisposed, inflammatory and pruritic skin disease. The variation in clinical presentations, due to genetic factors, extent of the lesions, stage of the disease, secondary infections, as well as resemblance to other non-atopic related skin diseases, can complicate a diagnosis of canine AD. A sub-group of the International Committee for Allergic Diseases in Animals (ICADA) was tasked with the development of a set of practical guidelines that can be used to assist practitioners and researchers in the diagnosis of canine AD. Online citation databases and abstracts from international meetings were searched for publications related to the topic, and combined with expert opinion where necessary. The final set of guidelines was approved by the entire ICADA committee. A total of 81 publications relevant for this review were identified. The guidelines generated focus on three aspects of the diagnostic approach: The diagnosis of canine AD is based on meeting clinical criteria and ruling out other possible causes with similar clinical signs. Flea combing, skin scraping and cytology should be performed, where necessary, as part of a thorough work-up. Elimination diet trials are required for patients with perennial pruritus and/or concurrent gastrointestinal signs. Once a clinical diagnosis of canine AD is made, allergy testing can be performed to identify potential causative allergens for allergen-specific immunotherapy.